Global Custom Market Research Reports Provider Company

phone

Intellipharmaceutics International Inc. (I) - Financial and Strategic SWOT Analysis Review

  • Published Date: 01 Feb 2015
  • Number of Pages: 25
  • Category: Healthcare and Medical
  • Country: Canada

Summary

Intellipharmaceutics International Inc. (Intellipharmaceutics) is a pharmaceutical company. The company holds expertise in research, development and manufacture of novel and generic targeted-release and controlled-release oral solid dosage drugs. Its product portfolio includes Rexista Oxycodone, Regabatin XR, Generic Focalin XR, Generic Effexor XR, Generic Protonix, Generic Glucophage XR, Generic Seroquel XR, Generic Lamictal XR, Generic Keppra XR and Generic Pristiq. Intellipharmaceutics offers products in the areas of neurology, gastrointestinal tract, cardiovascular, diabetes and pain. The company’s technology portfolio includes IntelliFoam, IntelliGITransporter, IntelliMatrix, IntelliOsmotics, IntelliPaste, IntelliShuttle, and IntelliPellets among others. It has partnership with Par Pharmaceutical, Inc. The company was formerly known as Intellipharmaceutics Ltd. Intellipharmaceutics is headquartered in Toronto, Ontario, Canada.

Intellipharmaceutics International Inc. Key Recent Developments

Dec 02, 2013: Intellipharmaceutics to Present at the 25th Annual Piper Jaffray Healthcare Conference
Nov 27, 2013: Intellipharmaceutics announces at-the-market offering of common shares
Oct 01, 2013: Intellipharmaceutics Announces Third Quarter 2013 Results
Jul 02, 2013: Intellipharmaceutics Announces Second Quarter 2013 Results
Apr 24, 2013: Intellipharmaceutics Announces Webcast of Presentation at the 12th Annual Needham Healthcare Conference

This comprehensive SWOT profile of Intellipharmaceutics International Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Intellipharmaceutics International Inc. including:and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief Summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Publisher Name : GlobalData

Section 1 - About the Company

Intellipharmaceutics International Inc. - Key Information
Intellipharmaceutics International Inc. - Overview
Intellipharmaceutics International Inc. - Key Employees
Intellipharmaceutics International Inc. - Key Employee Biographies
Intellipharmaceutics International Inc. - Key Operational Heads
Intellipharmaceutics International Inc. - Major Products and Services
Intellipharmaceutics International Inc. - History
Intellipharmaceutics International Inc. - Company Statement
Intellipharmaceutics International Inc. - Locations And Subsidiaries
Intellipharmaceutics International Inc. - Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

Intellipharmaceutics International Inc. - Business Description
Intellipharmaceutics International Inc. - Corporate Strategy
Intellipharmaceutics International Inc. - SWOT Analysis
SWOT Analysis - Overview
Intellipharmaceutics International Inc. - Strengths
Intellipharmaceutics International Inc. - Weaknesses
Intellipharmaceutics International Inc. - Opportunities
Intellipharmaceutics International Inc. - Threats
Intellipharmaceutics International Inc. - Key Competitors

Section 3 - Company Financial Performance Charts

Intellipharmaceutics International Inc. - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer


Note*: Some sections may be missing if data is unavailable for the company



List Of Tables

Intellipharmaceutics International Inc., Key Information
Intellipharmaceutics International Inc., Key Ratios
Intellipharmaceutics International Inc., Share Data
Intellipharmaceutics International Inc., Major Products and Services
Intellipharmaceutics International Inc., History
Intellipharmaceutics International Inc., Key Employees
Intellipharmaceutics International Inc., Key Employee Biographies
Intellipharmaceutics International Inc., Key Operational Heads
Intellipharmaceutics International Inc., Other Locations
Intellipharmaceutics International Inc., Subsidiaries
Intellipharmaceutics International Inc., Key Manufacturing facilities
Intellipharmaceutics International Inc., Key Competitors
Intellipharmaceutics International Inc., SWOT Analysis
Intellipharmaceutics International Inc., Ratios based on current share price
Intellipharmaceutics International Inc., Annual Ratios
Intellipharmaceutics International Inc., Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios



List Of Figures

Intellipharmaceutics International Inc., Performance Chart
Intellipharmaceutics International Inc., Ratio Charts



Intellipharmaceutics International Inc (IPCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

View Report

Intellipharmaceutics International Inc (Intellipharmaceutics) is a drug development company that develops and manufactures innovative and generic controlled-release and targeted-release oral solid dosage medicines. The company uses proprietary Hypermatrix technology, a

View Report

Intellipharmaceutics International Inc (Intellipharmaceutics) is a drug development company that develops and manufactures innovative and generic controlled-release and targeted-release oral solid dosage medicines. The company uses proprietary Hypermatrix technology, a

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports